Research Background on CJC-1295 Ipamorelin Blend CJC-1295 (No DAC) is a modified growth hormone releasing hormone analog consisting of 29 amino acids with substitutions at positions 2, 8, 15, and 27 to improve metabolic stability and receptor binding affinity
HSA/FSA Consideration: The website displays "HSA/FSA Approved!" in marketing materials
Antioxidants like vitamin E to protect the active and skin
The SURMOUNT-1 trial showed mean weight reductions of 15.0%, 19.5%, and 20.9% at the 5, 10, and 15 mg weekly doses over 72 weeks (Jastreboff et al., 2022)
They work by activating receptors in the gut and brain that regulate hunger, fullness, and blood sugar
We chose to collect data from 2007 onwards as both GLP-1 RAs and DPP-4is became available in Denmark in 2007